SPIA
TARO

Steward Partners Investment Advisory’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Steward Partners Investment Advisory’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$3.69K – 7471
2021
Q1 		$3.69K Buy
+50
New +$3.8K ﹤0.01% 3086

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Steward Partners Investment Advisory's TARO Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 50 shares — an estimated $3.69K sold.

Steward Partners Investment Advisory first reported a position in TARO in Q1 2021 and held it in 1 quarter. The position peaked at $3.69K in Q1 2021. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 50 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $3.69K.
  • Steward Partners Investment Advisory first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Taro Pharmaceutical Industries Ltd. position peaked at $3.69K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.